Guangzhou Diqi Pharmaceuticals

Guangzhou Diqi Pharmaceuticals is a clinical-stage biopharmaceutical company based in Guangzhou, China, specializing in the development of high-end complex formulations and advanced drug delivery systems. The company focuses on long-acting injectable (LAI) technologies, including microspheres and in-situ forming implants, designed to improve patient compliance and therapeutic outcomes for chronic conditions. Their pipeline primarily targets central nervous system (CNS) disorders, metabolic diseases, and chronic pain management. Diqi Pharmaceuticals leverages its proprietary technology platforms to develop both improved versions of existing drugs via the 505(b)(2) pathway and innovative new chemical entities. The company maintains its own R&D and GMP manufacturing facilities to support its clinical development and commercialization goals.